Last update 21 Nov 2024

Aflibercept Biosimilar (Rophibio)

Overview

Basic Info

Drug Type
Biosimilar, Fusion protein
Synonyms
Target
PGF x VEGF-A
Mechanism
PGF inhibitors(Placental Growth Factor inhibitors), VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors)
Therapeutic Areas
Congenital DisordersEye Diseases
Active Indication
Wet age-related macular degenerationAge Related Macular Degeneration
Inactive Indication-
Originator Organization
Rophibio Co., Ltd
Active Organization
Rophibio Co., Ltd
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Aflibercept Biosimilar (Rophibio)
CTIS2023-509206-29-00 / Not yet recruiting
A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneration - PD-CP-Y1
NCT06470373 / Not yet recruitingPhase 3
A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
100 Clinical Results associated with Aflibercept Biosimilar (Rophibio)
Login to view more data
100 Translational Medicine associated with Aflibercept Biosimilar (Rophibio)
Login to view more data
100 Patents (Medical) associated with Aflibercept Biosimilar (Rophibio)
Login to view more data
100 Deals associated with Aflibercept Biosimilar (Rophibio)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet age-related macular degenerationPhase 3
US
Rophibio Co., Ltd
01 Sep 2024
Age Related Macular DegenerationPhase 3
KR
Rophibio Co., Ltd
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free